Metabolic testing involves assessment of health and wellbeing of an individual. Metabolic testing equipment are used to screen organ functions and disease conditions such as liver diseases, diabetes, kidney diseases, and cardiovascular diseases. Metabolism is a chemical reaction occurring in the body to maintain the standard state of the organism or body. Metabolic syndrome is a group of metabolic disorders such as high blood pressure with high fasting glucose levels and abnormal obesity. Metabolism pattern and metabolic capacity is determined with the help of metabolic testing for management of such conditions. In case of sports professionals, metabolic testing is done in order to test the body’s ability of oxygen consumption.
Global metabolic testing market size was valued at US$ 596.3 million in 2022 and is expected to witness a CAGR of 7.6 % over the forecast period (2022 – 2030).
Figure 1. Global Metabolic Testing Market Share (%), by Product type, 2022
Increasing launch of metabolic carts by market players is expected to propel demand for metabolic testing devices.
Metabolic testing market is expected to witness significant growth over the forecast period, owing to increasing launches of new metabolic carts. For instance, on May, 2021, Lumen ,a health tech company, had officially been peer-reviewed and published in the Interactive Journal of Medical Research (I-JMR). In collaboration with San Francisco State University, Lumen had validated an ongoing study launched in 2020, which showed the validity of Lumen to detect changes in metabolic fuel utilization in a comparable manner with a laboratory standard metabolic cart, providing the ability for real-time metabolic information for users under any circumstances. Lumen has made metabolic testing accessible to measure metabolism from home via the CO2 exhaled from the breath.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2021 | Market Size in 2022: | US$ 596.3 Mn |
| Historical Data for: | 2017 to 2020 | Forecast Period: | 2022 to 2030 |
| Forecast Period 2022 to 2030 CAGR: | 7.6% | 2030 Value Projection: | US$ 1,074.9 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
COSMED srl, Vyaire Medical, Inc., Geratherm Medical AG, MGC Diagnostics Corporation, CORTEX Biophysik GmbH, General Electric Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc., AEI Technologies, Inc., KORR Medical Technologies, Inc., Iworx Systems, GE Healthcare, Hologic, Inc, Geratherm Medical AG, and Parvo Medics. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Figure 2. Global Metabolic Testing Market Share (%), by Region, 2022
Increasing prevalence of lifestyle diseases is expected to propel demand for metabolic testing devices.
Metabolic testing market is expected to witness significant growth over the forecast period, owing to increasing prevalence of lifestyle diseases such as type 2 diabetes, obesity, and cardiovascular diseases. For instance, on July 28, 2022 according to American Diabetes Association (ADA), in 2019, around 37.3 million people in the U.S. were suffering from diabetes. Whereas, nearly 1.9 million U.S. people had type 1 diabetes, including about 244,000 children and adolescents. Increasing prevalence of lifestyle diseases leads to high demand for metabolic testing, which in turn is expected to boost the global metabolic testing market growth.
Therefore, high prevalence of diabetes is expected to drive the global metabolic testing market growth over the forecast period.
Global Metabolic Testing Market– Impact of Coronavirus (COVID-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.
Increasing use of electrocardiography in coronavirus disease 2019 (COVID-19) has driven growth of the global metabolic testing market over the forecast period. For instance, in August 2020, National Center for Biotechnology Information, National Library of Medicine, published a report on Value of electrocardiography in coronavirus disease 2019 (COVID-19), which stated that electrocardiogram monitoring upholds a critical role in patient safety during the dose adjustment of medications used in the management of COVID-19. The electrocardiogram (ECG) is one of the major tools to assess the extent of cardiac involvement in COVID-19 patients, due to low cost, and the possibility of remote evaluation.
Hence use of electrocardiogram in covid-19 has driven growth of the global metabolic testing market over the forecast period.
Global Metabolic Testing Market: Key Developments
Global Metabolic Testing Market Restraints
Lifestyle diseases are still not considered as extremely serious and fatal in developed as well as emerging economies. Low awareness among people regarding metabolic testing and need for screening, prevention, and monitoring of lifestyle diseases is also expected to restrain the market growth.
Two tests are majorly conducted/used in metabolic testing. Resting Metabolic Rate (RMR) analysis is required in ICUs (Intensive care units) for hospitalized patients to track their health status and to devise precise nutritional requirements for such patients on the basis of their RMR analysis. VO2 max analysis is required by sports professionals and athletes so, these two tests have limited target population which may restrain growth of market. Body composition analysis is not performed extensively other than by fitness enthusiasts (to have high muscle to fat ratio for a muscular physique) and other purposes. These factors are expected to restrain growth of market to a certain extent.
Key Players
Key players operating in the global metabolic testing market include COSMED srl, Vyaire Medical, Inc., Geratherm Medical AG, MGC Diagnostics Corporation, CORTEX Biophysik GmbH, General Electric Company, Microlife Medical Home Solutions, Inc., OSI Systems, Inc., AEI Technologies, Inc., KORR Medical Technologies, Inc., Iworx Systems, GE Healthcare, Hologic, Inc, Geratherm Medical AG, and Parvo Medics.
Metabolic testing devices are medical devices used to screen organ functions and disease conditions such as liver diseases, diabetes, kidney diseases, and cardiovascular diseases. Technologies involved in metabolic testing include VO2 (the amount (volume) of oxygen your body) Max analysis, RMR(Resting metabolic rate) analysis, and body composition analysis. VO2 Max analysis includes body’s maximum rate of oxygen consumption that is measured during incremental exercise. RMR analysis is resting metabolic rate analysis in which measurement of food and energy required to maintain basic body functions such as heartbeat, breathing, and maintenance of body heat is done. Body composition analysis consists of determination of ratio of different tissues of the body. Metabolic testing is helpful in lifestyle disease management, performance testing for sports and fitness professionals, and in case of metabolic disorders such as diabetes. Products available in market work on either of these technologies such as RMR, VO2 Max, and body consumption analysis. Commercially available products for metabolic testing include, ReeVue, Quark RMR w/CPET, Quark CPET, K5, and Ultima CardiO2.
Increasing approval from the US Food & Drug Administration is expected to boost the global metabolic testing market. These devices require 510 (k) premarket notification to be sold in market. For instance, on March 2020, K5 wearable metabolic system (K5 expands the scope of metabolic testing from clinical exercise testing to performance assessment.)had a 510 (k) premarket notification granted by the U.S. Food & Drug Administration (FDA) to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device (section 513(i)(1)(A) FD&C Act).
Market Dynamics
Increasing approval and launch of new products, high prevalence of lifestyle diseases, are expected to be major factors driving metabolic testing market growth. For instance, on August 5, 2022, COSMED srl, a metabolic company, introduced products such as Quark CPET (Cosmed srl) with multiple configurations such as ECG testing and nutritional assessment and products such as ReeVue (Korr Medical Technologies Inc.) with mixing chamber technology, self-calibration, and reimbursement facility.
Prevalence of lifestyle diseases is high in key regions. Lifestyle diseases can lead to metabolic diseases which in turn is expected to drive demand for metabolic testing devices and drive metabolic testing market growth. For instance, on July 7, 2022, the state of food and and Nutrition in the World, published 2022 report on obesity, which stated that the prevalence of obesity in India’s adult population increased to 3.9 per cent in 2016 from 3.1 per cent in 2012 and anaemic women aged 15 to 49 years declined marginally from 53.2 per cent in 2012 to 53 per cent in 2019.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients